Allogenic Mesenchymal Stromal Cell Infusion Therapy for Children with Severe Generalised Recessive Dystrophic Epidermolysis Bullosa

Document first published:
Page updated:
Topic:
Publication type:
,

This clinical commissioning policy statement relates to the commissioning arrangements for allogenic mesenchymal stromal cell infusion therapy for children with severe generalised recessive dystrophic epidermolysis bullosa.

Document

Allogenic Mesenchymal Stromal Cell Infusion Therapy for Children with Severe Generalised Recessive Dystrophic Epidermolysis Bullosa Policy Statement

Allogenic Mesenchymal Stromal Cell Infusion Therapy for Children with Severe Generalised Recessive Dystrophic Epidermolysis Bullosa Policy Statement

  • PDF
  • 32 KB
  • 3 pages

Document

Stakeholder Engagement Report

Stakeholder Engagement Report

  • PDF
  • 28 KB
  • 2 pages

Document

CPAG Summary Report

CPAG Summary Report

  • PDF
  • 82 KB
  • 5 pages

Document

Clinical Panel Report

Clinical Panel Report

  • PDF
  • 121 KB
  • 2 pages